Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jeffrey Sawyer

Concepts (180)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Chromosomes, Human, Pair 1
8
2019
95
2.070
Why?
Multiple Myeloma
21
2024
3082
1.440
Why?
Scoliosis
5
2024
63
1.400
Why?
Translocation, Genetic
6
2019
266
1.220
Why?
Slipped Capital Femoral Epiphyses
2
2025
9
1.050
Why?
Orthopedic Procedures
2
2025
71
1.000
Why?
Orthopedics
3
2022
54
0.970
Why?
Bone Screws
1
2025
32
0.880
Why?
Ambulatory Surgical Procedures
1
2025
54
0.850
Why?
Fractures, Open
1
2022
8
0.710
Why?
Methicillin-Resistant Staphylococcus aureus
1
2022
83
0.660
Why?
Diagnostic Imaging
1
2021
176
0.610
Why?
Chromosomal Instability
1
2019
16
0.600
Why?
Staphylococcal Infections
1
2022
271
0.580
Why?
Pediatrics
1
2021
307
0.540
Why?
Child
12
2025
7384
0.490
Why?
Transplantation, Autologous
3
2024
488
0.450
Why?
Gene Amplification
2
2019
58
0.450
Why?
Heterochromatin
2
2009
4
0.440
Why?
Gene Dosage
1
2015
76
0.440
Why?
Chromosome Deletion
2
2017
138
0.420
Why?
Chromosomes, Human, Pair 17
1
2014
35
0.400
Why?
Humans
36
2025
53246
0.390
Why?
Melphalan
2
2016
180
0.360
Why?
Chromosome Aberrations
5
2016
297
0.350
Why?
Myelodysplastic Syndromes
2
2013
87
0.340
Why?
In Situ Hybridization, Fluorescence
4
2019
266
0.320
Why?
Follow-Up Studies
6
2024
2318
0.290
Why?
Retrospective Studies
7
2025
6821
0.270
Why?
Adolescent
6
2025
6912
0.270
Why?
Hematopoietic Stem Cell Transplantation
2
2024
610
0.270
Why?
Tomography, X-Ray Computed
2
2025
1183
0.270
Why?
Prognosis
8
2021
2118
0.270
Why?
Myeloablative Agonists
1
2007
32
0.260
Why?
Hematopoietic Stem Cell Mobilization
1
2007
63
0.260
Why?
Age of Onset
2
2024
109
0.260
Why?
Spinal Fusion
2
2024
73
0.230
Why?
Spondylolysis
1
2025
2
0.220
Why?
Male
14
2025
27444
0.220
Why?
Female
15
2025
28792
0.220
Why?
Disease Progression
3
2019
880
0.210
Why?
Bone Marrow
3
2022
359
0.210
Why?
Lumbar Vertebrae
1
2025
101
0.210
Why?
Firearms
1
2024
18
0.210
Why?
Perioperative Care
1
2024
44
0.200
Why?
Wounds, Gunshot
1
2024
34
0.200
Why?
Neoplasms, Second Primary
1
2024
75
0.200
Why?
Child, Preschool
4
2025
4164
0.200
Why?
Cost of Illness
1
2024
121
0.200
Why?
Neoplasm, Residual
2
2022
171
0.200
Why?
Postoperative Care
1
2024
109
0.200
Why?
Inpatients
1
2025
208
0.200
Why?
Cytogenetic Analysis
2
2014
79
0.190
Why?
Reoperation
1
2025
476
0.190
Why?
Clubfoot
1
2022
2
0.180
Why?
Mutation
2
2020
1338
0.180
Why?
Foot Orthoses
1
2022
7
0.180
Why?
Radiologic Health
1
2021
2
0.170
Why?
Risk Adjustment
1
2021
17
0.170
Why?
Gene Expression Regulation, Neoplastic
4
2016
868
0.160
Why?
Fasting
1
2020
76
0.160
Why?
Treatment Outcome
4
2025
5597
0.160
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Research Design
1
2022
373
0.150
Why?
Proto-Oncogene Proteins B-raf
1
2020
78
0.150
Why?
Karyotyping
3
2017
77
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
1043
0.140
Why?
Syndrome
1
2019
248
0.140
Why?
Adult
7
2024
14541
0.140
Why?
Quality of Life
1
2024
902
0.140
Why?
Karyotype
2
2017
22
0.140
Why?
Postoperative Complications
1
2025
1099
0.130
Why?
Chromosome Disorders
1
2017
32
0.130
Why?
Thalidomide
2
2016
378
0.130
Why?
Genetic Association Studies
1
2017
124
0.130
Why?
Gene Expression Profiling
6
2014
1112
0.120
Why?
Antibodies, Monoclonal
1
2019
477
0.120
Why?
Young Adult
2
2024
4514
0.120
Why?
Anti-Bacterial Agents
1
2022
832
0.110
Why?
Aged
9
2024
10430
0.110
Why?
Genome, Human
1
2015
121
0.110
Why?
Genetic Predisposition to Disease
1
2017
533
0.110
Why?
Alleles
1
2015
277
0.110
Why?
Neoplasm Recurrence, Local
2
2022
647
0.110
Why?
Interspersed Repetitive Sequences
1
2014
7
0.100
Why?
Gene Fusion
2
2014
9
0.100
Why?
Chromosomes, Human, Pair 14
1
2014
76
0.100
Why?
Metaphase
2
2016
47
0.100
Why?
Bone Marrow Cells
1
2014
188
0.100
Why?
Risk
1
2014
306
0.100
Why?
Leukemia
1
2013
67
0.090
Why?
Consensus
2
2024
206
0.090
Why?
Transcription Factors
1
2015
571
0.090
Why?
Risk Factors
4
2025
4018
0.090
Why?
Epigenesis, Genetic
1
2015
412
0.090
Why?
Infant
3
2025
3808
0.080
Why?
Observer Variation
2
2022
138
0.080
Why?
DNA Methylation
1
2015
592
0.080
Why?
Reproducibility of Results
3
2022
1221
0.080
Why?
Middle Aged
6
2024
13422
0.080
Why?
Survival Rate
3
2020
949
0.080
Why?
Chromosome Breakage
1
2009
16
0.080
Why?
Neoplasms
1
2017
1335
0.070
Why?
Disease-Free Survival
2
2019
466
0.060
Why?
Age Distribution
1
2007
175
0.060
Why?
Prospective Studies
2
2016
2412
0.060
Why?
Chromosome Banding
1
2006
24
0.060
Why?
Models, Genetic
1
2006
169
0.060
Why?
Kaplan-Meier Estimate
1
2007
487
0.060
Why?
Paraproteinemias
1
2006
72
0.060
Why?
Leukemia, Myeloid, Acute
1
2007
208
0.060
Why?
Cyclin D1
1
2005
59
0.050
Why?
Predictive Value of Tests
1
2007
933
0.050
Why?
Databases, Factual
1
2007
742
0.050
Why?
Travel
1
2024
37
0.050
Why?
Delphi Technique
1
2024
71
0.050
Why?
Survival Analysis
2
2021
659
0.050
Why?
Morphine
1
2023
103
0.050
Why?
Analgesics
1
2023
104
0.040
Why?
Braces
1
2022
9
0.040
Why?
Pain, Postoperative
1
2023
169
0.040
Why?
Prevalence
1
2025
1034
0.040
Why?
Dexamethasone
1
2024
429
0.040
Why?
Arkansas
1
2007
2068
0.040
Why?
Epiphyses
1
2021
6
0.040
Why?
Practice Guidelines as Topic
1
2024
502
0.040
Why?
Hunger
1
2020
16
0.040
Why?
Conscious Sedation
1
2020
19
0.040
Why?
Lower Extremity
1
2022
103
0.040
Why?
Evidence-Based Medicine
1
2022
275
0.040
Why?
Patient Compliance
1
2022
232
0.040
Why?
Radiography
1
2021
476
0.040
Why?
Phenotype
2
2017
803
0.040
Why?
DNA Mutational Analysis
1
2020
179
0.040
Why?
Centromere
1
1998
10
0.030
Why?
Time Factors
1
2024
2992
0.030
Why?
Chromosomes, Human, Pair 22
1
2017
38
0.030
Why?
Genetic Testing
1
2017
130
0.030
Why?
Emergency Service, Hospital
1
2020
530
0.030
Why?
Chromosome Mapping
2
2006
145
0.030
Why?
Electroencephalography
1
2017
309
0.030
Why?
Cyclins
2
2006
38
0.030
Why?
Hepatocyte Growth Factor
1
2015
11
0.030
Why?
Risk Assessment
1
2019
1368
0.030
Why?
Binding Sites
1
2015
373
0.030
Why?
Neoplasm Proteins
1
2016
330
0.030
Why?
United States
1
2024
5413
0.020
Why?
Promoter Regions, Genetic
1
2015
465
0.020
Why?
Polymorphism, Single Nucleotide
1
2015
505
0.020
Why?
Boronic Acids
1
2013
180
0.020
Why?
Pyrazines
1
2013
188
0.020
Why?
Comparative Genomic Hybridization
1
2012
38
0.020
Why?
Microarray Analysis
1
2012
69
0.020
Why?
RNA, Messenger
2
2006
1133
0.020
Why?
Acute Disease
1
2013
393
0.020
Why?
Biopsy, Needle
1
2012
181
0.020
Why?
Cell Line, Tumor
1
2015
1470
0.020
Why?
Models, Statistical
1
2012
229
0.020
Why?
Magnetic Resonance Imaging
1
2017
1587
0.020
Why?
Incidence
1
2013
1085
0.020
Why?
Sensitivity and Specificity
1
2012
869
0.020
Why?
Case-Control Studies
1
2012
1212
0.020
Why?
Multigene Family
1
2006
50
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
37
0.020
Why?
RNA, Neoplasm
1
2006
45
0.010
Why?
Syndecan-1
1
2006
73
0.010
Why?
Proteoglycans
1
2006
86
0.010
Why?
Cluster Analysis
1
2006
238
0.010
Why?
Data Interpretation, Statistical
1
2006
169
0.010
Why?
Cyclin D3
1
2005
5
0.010
Why?
Cyclin D2
1
2005
21
0.010
Why?
Trisomy
1
2005
34
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2006
412
0.010
Why?
Membrane Glycoproteins
1
2006
238
0.010
Why?
Proportional Hazards Models
1
2006
445
0.010
Why?
Recurrence
1
2006
694
0.010
Why?
Plasma Cells
1
2006
234
0.010
Why?
Bone Diseases
1
2005
94
0.010
Why?
Cohort Studies
1
2006
1557
0.010
Why?
Sawyer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description